Smith & Wesson’s Turnaround Is Real — the Catch Is Whether the Cash Holds

Smith & Wesson swung back to profit this past quarter, earning $0.06 a share against a $0.08 loss a year earlier, in the seasonally weakest quarter the company has. The stock has rallied more than 30% this year, and the market cap sits near $590 million. It looks like the beaten-down inflection story this setup is supposed to reward — and for once, the numbers partly support it. The catch, as with any gun maker that just dug itself out of a demand bust, is deciding whether the cheap price is an entry or a trap. The one metric that answers it is free cash flow, and it does not flatter the company as cleanly as the earnings headline does.

The profit is real, and it is cash-backed

Start with the part that separates this from a pure beaten-down-stock recap. Smith & Wesson reports on a fiscal year ending April 30, and fiscal 2026 — which closed last spring — was a genuine recovery: revenue of $523.8 million, up about 10% year over year, with net income of $18.5 million in a business that had been swinging to losses a year earlier. The strongest quarter, the fourth, delivered net sales up 26.7% to $178.4 million and earnings of $0.36 a share.

The more important evidence sits on the balance sheet and cash-flow statement, because that is what a turnaround like this is really tested on. Over fiscal 2026 the company retired $60 million of debt, ending the year with roughly $20 million in notes payable against $80 million a year earlier, and cash enough to call the net position a positive $8.2 million. Behind that, trailing-twelve-month operating cash flow is about $113 million and free cash flow after capital spending is around $82 million. That is the hard proof the story needs: a gun maker that went through the post-boom inventory bust, rebuilt its margins, and started throwing off cash again rather than burning it.

The catch: the cheapest numbers were flattered

Here is where the headline deserves a pause. The first quarter of fiscal 2027 — the three months through July 31 — reported gross margin up to 28.7% from 25.9%, and that looked like the turnaround compounding. But the company disclosed that the quarter included a $2.9 million tariff refund it labels a non-recurring benefit, which alone added roughly 260 basis points to gross margin. Strip that out and the underlying margin was close to flat with a year earlier. The profit is real — net income of $2.6 million versus a $3.4 million loss — but the margin expansion that made the quarter look special was partly a one-time item.

The seasonality reads the same way. The first fiscal quarter is normally Smith & Wesson’s slowest, and it still burned cash: operating cash flow was negative $8.8 million, free cash flow negative $20.8 million because capex jumped to $11.9 million, and cash on hand fell from $28.2 million to $18.7 million while notes payable roughly doubled to $39.2 million. None of that is alarming by itself — it is the standard rhythm of a seasonal business that does its real cash earning in the second half — but it explains why the trailing $82 million of free cash flow is not a steady monthly drum. It is a figure earned mostly in the strong half, and the company itself has flagged the pressures that could pull it back down: handgun average selling prices expected to fall roughly 5%, an effective tax rate stepping up toward 30%, and higher capital spending as it invests in its Springfield plant.

What the ~7× free-cash-flow price actually asks of you

Put it together and the stock is not the screaming bargain the surface makes it look. Roughly $82 million of trailing free cash flow against a ~$590 million market cap is a low-single-digit multiple — around 7× — and the $0.13 quarterly dividend is a real ~4% yield on top of it. Those are the reasons a beaten-down value investor stops to look. The catch is that this price is only meaningful if that cash flow holds, and the market has already taken the easy part of the trade: the stock is up more than 30% year to date, and the aggregate rating signal labels it a Buy. The expectations reset that makes this style work comfortably is largely spent.

So the remaining question is narrower and more honest than "is Smith & Wesson turning around?" — that part is answered. The question is whether the $82 million is the new run-rate or the top of a swing. The proof path is a simple one: watch whether full-year free cash flow holds near the roughly $90 million pace the company reported for fiscal 2026 as the tariff refund rolls off, the handgun average selling price fades, and capex and the tax bill climb. If it holds in that neighborhood, the low multiple re-rates because the cash is durable. If the one-offs reverse and the price declines plus a higher effective tax rate clamp free cash down into the mid-$60s or lower, then the cheap trailing multiple was the old value-trap story in new clothing, and the operating case has broken.

I can be wrong here — cash flow is exactly the kind of proof that can disappoint after a cyclical recovery, and this is a political and demand-driven business where the recent surge may owe as much to the moment as to the model. But the disciplined read is to stop trusting the profit headline and start holding the company to its cash. If that holds, the catch is small and the turnaround keeps compounding. If it slips, the market was not wrong to be skeptical. The cash-flow statement, not the EPS tick, is the tripwire that decides which Smith & Wesson you actually own.